Abstract:To explore the clinical efficacy of biomedical ceramic iRoot BP in the treatment of localized acute pulpitis in children, and the effect of iRoot BP on proliferation and osteogenic differentiation of human dental pulp stem cells (hDPSCs), 72 localized acute pulpitis children admitted to our hospital from September 2018 to September 2019 were selected and divided into group A (treated with MTA pulp capping material) and group B (treated with iRoot BP material), and the clinical effect, pain degree, and adverse reactions (ADR) rate were compared. The effects of iRoot BP on hDPSCs proliferation and osteogenic differentiation were analyzed; the proliferative activity of cells in iRoot BP group, MTA group, and control group (C group) were measured by cholecystokinin-8 (CCK-8) assay, the ability of cell mineralized nodular formation was observed via alizarin red staining; and quantitative reverse transcription PCR (qRT-PCR) andWestern blot were adopted to determine the expression of osteogenic related genes of hDPSCs and key proteins of mitogen-activated protein kinase (MAPK) signaling pathway. After 1 week of treatment, the clinical efficacy of group B was more favorable in contrast with group A ( P < 0.05); the pain of children in group B was notably better in contrast with group A, and incidence of ADR was notably lower in contrast with group A ( P < 0.05). 5.0 mg/mL, 10.0 mg/mL, and 30 mg/mL iRoot BP or MTA could improve cell proliferation activity ( P < 0.01); the effect of iRoot BP on proliferation of hDPSCs was greater in contrast with MTA ( P < 0.05); and the integral optical density (IOD) value of iRoot BP group was notably higher in contrast with MTA group ( P < 0.01). The mRNA expression levels of collagen-I (COL-I), bone sialoprotein (BSP), and osteocalcin (OC) in MTA group and iRoot BP group were notably higher in contrast with C group ( P < 0.01); the COL-I mRNA expression level of iRoot BP group was notably higher in contrast with MTA group ( P < 0.01); the mRNA expression level of BSP in MTA group was notably higher in contrast with iRoot BP group ( P < 0.01); the relative protein expression levels of phosphorylated ERK (p-ERK) and phospho-Jun N-terminal kinase (p-JNK) in MTA group and iRoot BP group were notably higher in contrast with C group ( P < 0.01); and the relative expression level of p-ERK protein in iRoot BP group was higher in contrast with MTA group ( P < 0.05). These results indicated that the clinical efficacy of biomedical ceramic iRoot BP was better than MTA in the preservation of live pulpitis in children, and the patients treated with iRoot BP had better pain recovery effect and lower risk of ADR. The effect of iRoot BP on the proliferation and mineralization of hDPSCs was better than that of MTA, and it may promote the osteogenic differentiation of hDPSCs by activating MAPK signaling pathway and regulating gene expression of COL-I, BSP, and OC.

Evaluation of a Bioceramic as a Pulp Capping Agent In Vitro and In Vivo

Outcome of Root Canal Treatment Using Warm Vertical Compaction with Bioceramic and Resin-Based Sealers: A Randomised Clinical Trial.

In vitro and in vivo evaluation of iRoot BP Plus as a coronal sealing material for regenerative endodontic procedures

[Effect of Iroot BP Plus on Biological Behavior of Deciduous Tooth Pulp Stem Cells and Human Pulp Stem Cells].

The combined application of rat bone marrow mesenchymal stem cells and bioceramic materials in the regeneration of dental pulp-like tissues

The Effect of Partial Pulpotomy with Iroot BP Plus in Traumatized Immature Permanent Teeth: A Randomized Prospective Controlled Trial.

Effects of Novel Nanoparticulate Bioceramic Endodontic Material on Human Dental Pulp Stem Cells In Vitro

[Application of bioactive ceramics iRoot BP Plus® in pulpotomy for complicated crown fracture of immature permanent anterior teeth in children]

In Vitro Study of Dentinal Tubule Penetration and Filling Quality of Bioceramic Sealer

In vitro evaluation of the impact of a bioceramic root canal sealer on the mechanical properties of tooth roots

Experimental Pulp-Capping Agent Radiopaque Dicalcium Silicate Cement Facilitates Dentinogenesis

Adoption of Biomedical Ceramic iRoot BP in the Treatment of Localized Pulpitis in Children

Concentrated growth factor combined with iRoot BP Plus promotes inflamed pulp repair: an in vitro and in vivo study

Clinical application of calcium silicate-based bioceramics in endodontics

[Clinical Efficacy Observation of Direct Pulp Capping Using Iroot BP Plus Therapy in Mature Permanent Teeth with Carious Pulp Exposure].

Multivariate Prognostic Analysis of Direct Pulp Capping Using a Bioceramic Material in Mature Permanent Teeth with Carious Pulp Exposure: a Retrospective Cohort Study

Biocompatibility and pro-mineralization effects of premixed calcium silicate-based materials on human dental pulp stem cells: An in vitro and in vivo study

An in Vitro Investigation of the Mechanical-Chemical and Biological Properties of Calcium Phosphate/Calcium Silicate/Bismutite Cement for Dental Pulp Capping

Effect of pulp capping materials on odontogenic differentiation of human dental pulp stem cells: An in vitro study

Evaluation of biocompatibility and bioactive potential of Well-Root PT by comparison with ProRoot MTA and Biodentine

Effects of silicate-based composite material on the proliferation and mineralization behaviors of human dental pulp cells: An in vitro assessment